Skip to main content

Advertisement

SpringerLink
Log in

Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

The etiology of bone fragility in individuals with type 1 diabetes is unknown. This study demonstrated that bone turnover favors resorption and that poor glycemic control is associated with low bone mineral density (BMD) and low bone turnover, in premenopausal women with type 1 diabetes. The results could inform future interventions.

Introduction

Low BMD and fracture may be complications of type 1 diabetes. We sought to determine the roles of bone turnover and glycemic control in the etiology of low BMD.

Methods

Premenopausal women from the Wisconsin Diabetes Registry Study and matched controls were compared (n = 75 pairs). Heel and forearm BMD were measured, and hip and spine BMD were measured in a subset. Markers of bone formation (osteocalcin) and resorption (NTx), and glycemic control (HbA1c) were determined.

Results

Age ranged from 18 to 50 years with a mean of 28, and 97% were Non-Hispanic white. Among women with diabetes, mean disease duration was 16 years and current HbA1c was 8%. Compared to controls, women with diabetes had a high prevalence of previous fracture (37% vs. 24%) and low BMD for age (heel or forearm: 49% vs. 31%), low heel and forearm BMD, and low osteocalcin levels. Levels of NTx were similar, suggesting uncoupled turnover favoring resorption. Poor glycemic control was associated with low BMD at all bone sites except the spine, and with low osteocalcin and NTx levels.

Conclusions

Optimal glycemic control may prevent low BMD and altered bone turnover in type 1 diabetes, and decrease fracture risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Brown SA, Sharpless JL (2004) Osteoporosis: an under-appreciated complication of diabetes. Clinical Diabetes 22:10–20

    Article  Google Scholar 

  2. Janghorbani M, Van Dam R, Willett W et al (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Amer J Epidemiol 166:495–505

    Article  Google Scholar 

  3. DIAMOND Project Group (2006) Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866

    Article  Google Scholar 

  4. Matsushima M, LaPorte RE, Maruyama M et al (1997) Geographic variation in mortality among individuals with youth-onset diabetes mellitus across the world. DERI Mortality Study Group. Diabetes Epidemiology Research International. Diabetologia 40:212–216

    Article  PubMed  CAS  Google Scholar 

  5. Carnevale V, Romagnoli E, D'Erasmo E (2004) Skeletal involvement in patients with diabetes mellitus. Diabetes Metab Res Rev 20:196–204

    Article  PubMed  Google Scholar 

  6. Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18:427–444

    Article  PubMed  CAS  Google Scholar 

  7. Hofbauer LC, Brueck CC, Singh SK et al (2007) Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 22:1317–1328

    Article  PubMed  CAS  Google Scholar 

  8. Gallacher SJ, Fenner JA, Fisher BM et al (1993) An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitus. Diabet Med 10:129–133

    Article  PubMed  CAS  Google Scholar 

  9. Gunczler P, Lanes R, Paz-Martinez V et al (1998) Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol 11:413–419

    CAS  Google Scholar 

  10. Liu EY, Wactawski-Wende J, Donahue RP et al (2003) Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care 26:2365–2369

    Article  PubMed  Google Scholar 

  11. Ponder SW, McCormick DP, Fawcett HD et al (1992) Bone mineral density of the lumbar vertebrae in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr 120:541–545

    Article  PubMed  CAS  Google Scholar 

  12. Miazgowski T, Czekalski S (1998) A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus. Osteoporos Int 8:399–403

    Article  PubMed  CAS  Google Scholar 

  13. Moyer-Mileur LJ, Dixon SB, Quick JL et al (2004) Bone mineral acquisition in adolescents with type 1 diabetes. J Pediatr 145:662–669

    Article  PubMed  Google Scholar 

  14. Strotmeyer ES, Cauley JA, Orchard TJ et al (2006) Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 29:306–311

    Article  PubMed  Google Scholar 

  15. Pascual J, Argente J, Lopez MB et al (1998) Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onset. Calcif Tissue Int 62:31–35

    Article  PubMed  CAS  Google Scholar 

  16. Valerio G, del Puente A, Esposito-Del Puente A et al (2002) The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 58:266–272

    Article  PubMed  CAS  Google Scholar 

  17. Tuominen JT, Impivaara O, Puukka P et al (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22:1196–1200

    Article  PubMed  CAS  Google Scholar 

  18. Palta M, LeCaire T, Daniels K et al (1997) Risk factors for hospitalization in a cohort with type 1 diabetes. Wisconsin Diabetes Registry. Amer J Epidemiol 146:627–636

    CAS  Google Scholar 

  19. World Health Organization (ed) (1985) Diabetes Mellitus: Report of a WHO Study Group. Technical Report Series 727. WHO, Geneva

  20. Prince R, Sipos A, Hossain A et al (2005) Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment. J Bone Miner Res 20:1507–1513

    Article  PubMed  CAS  Google Scholar 

  21. Cummings SR, Bates D, Black DM (2002) Clinical use of bone densitometry: scientific review. JAMA 288:1889–1897

    Article  PubMed  Google Scholar 

  22. Cummings SR, Black DM, Nevitt MC et al (1993) Bone density at various sites for prediction of hip fractures: the Study of Osteoporotic Fractures Research Group. Lancet 341:72–75

    Article  PubMed  CAS  Google Scholar 

  23. Binkley N, Bilezikian JP, Kendler DL et al (2007) Summary of the international society for clinical densitometry 2005 position development conference. J Bone Miner Res 22:643–645

    Article  PubMed  Google Scholar 

  24. Eastell R, Robins SP, Colwell T et al (1993) Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int 3:255–260

    Article  PubMed  CAS  Google Scholar 

  25. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986

    Article  Google Scholar 

  26. Duck SC, Lee M, D'Alessio D (1990) 24–42 month stability of internal blood standards for glycated hemoglobin analysis. Diabetes Res Clin Pract 9:195–199

    Article  PubMed  CAS  Google Scholar 

  27. Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Amer J Epidemiol 122:51–65

    CAS  Google Scholar 

  28. Sallis JF, Haskell WL, Wood PD et al (1985) Physical activity assessment methodology in the Five-City Project. Amer J Epidemiol 121:91–106

    CAS  Google Scholar 

  29. Gorai I, Chaki O, Nakayama M et al (1995) Urinary biochemical markers for bone resorption during the menstrual cycle. Calcif Tissue Int 57:100–104

    Article  PubMed  CAS  Google Scholar 

  30. Pasco JA, Henry MJ, Kotowicz MA et al (2004) Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 19:752–758

    Article  PubMed  CAS  Google Scholar 

  31. Clowes JA, Khosla S, Eastell R (2005) Potential role of pancreatic and enteric hormones in regulating bone turnover. J Bone Miner Res 20:1497–1506

    Article  PubMed  CAS  Google Scholar 

  32. Peduzzi P, Concato J, Kemper E et al (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379

    Article  PubMed  CAS  Google Scholar 

  33. Looker AC, Bauer DC, Chesnut CH III et al (2000) Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 11:467–480

    Article  PubMed  CAS  Google Scholar 

  34. Garnero P, Hausherr E, Chapuy M-C et al (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 11:1531–1538

    Article  PubMed  CAS  Google Scholar 

  35. Verhaeghe J, van Herck E, Visser WJ et al (1990) Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 39:477–482

    Article  PubMed  CAS  Google Scholar 

  36. Ward DT, Yau SK, Mee AP et al (2001) Functional, molecular, and biochemical characterization of streptozotocin-induced diabetes. J Am Soc Nephrol 12:779–790

    PubMed  CAS  Google Scholar 

  37. Bouillon R (1991) Diabetic bone disease. Calcif Tissue Int 49:155–160

    Article  PubMed  CAS  Google Scholar 

  38. Nathan DM, Cleary PA, Backlund JY et al Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653

    Article  Google Scholar 

  39. Katayama Y, Akatsu T, Kado TS et al (1995) Glycated bone collagen in diabetic rats and its effects on osteoblast functions (abstract 535). Bone 16:219S

    Google Scholar 

  40. Lee NK, Sowa H, Hinoi E et al (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456–469

    Article  PubMed  CAS  Google Scholar 

  41. Rozadilla A, Nolla JM, Montana E et al (2000) Bone mineral density in patients with type 1 diabetes mellitus. Joint Bone Spine 67:215–218

    PubMed  CAS  Google Scholar 

  42. Pocock NA, Eisman JA, Hopper JL et al (1987) Genetic determinants of bone mass in adults: a twin study. J Clin Invest 80:706–710

    Article  PubMed  CAS  Google Scholar 

  43. Sowers MR, Galuska DA (1993) Epidemiology of bone mass in premenopausal women. Epidemiol Rev 15:374–398

    PubMed  CAS  Google Scholar 

  44. Henry YM, Fatayerji D, Eastell R (2004) Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density. Osteoporos Int 15:263–273

    Article  PubMed  Google Scholar 

  45. U.S. Preventive Services Task Force (2002) Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 137:526–528

    Google Scholar 

Download references

Funding

American Diabetes Association grant 1-05-CR-35, National Institutes of Health grant DK036904. We gratefully acknowledge the study participants and staff of the Wisconsin Women & Diabetes Study, Wisconsin Diabetes Registry Study, and Osteoporosis Clinic Research Program.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Institute for Endocrine Discovery and Clinical Care, University of Chicago, Chicago, IL, USA

    K. K. Danielson

  2. Pharmacy Practice Division, University of Wisconsin—Madison, Madison, WI, USA

    M. E. Elliott

  3. Department of Population Health Sciences, University of Wisconsin—Madison, Madison, WI, USA

    T. LeCaire & M. Palta

  4. Department of Medicine, University of Wisconsin—Madison, Madison, WI, USA

    N. Binkley

  5. Department of Biostatistics and Medical Informatics, University of Wisconsin—Madison, Madison, WI, USA

    M. Palta

  6. 5841 S. Maryland Avenue, MC 5053, Chicago, IL 60637, USA

    K. K. Danielson

Authors
  1. K. K. Danielson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. E. Elliott
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. LeCaire
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Binkley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Palta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. K. Danielson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Danielson, K.K., Elliott, M.E., LeCaire, T. et al. Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes. Osteoporos Int 20, 923–933 (2009). https://doi.org/10.1007/s00198-008-0763-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-008-0763-3

Keywords

Search

Navigation